Literature DB >> 2178847

Clinical pharmacokinetics 1990.

G R Matzke1, W L St Peter.   

Abstract

Mesh:

Year:  1990        PMID: 2178847     DOI: 10.2165/00003088-199018010-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  123 in total

1.  Age-associated stereoselective alterations in hexobarbital metabolism.

Authors:  M H Chandler; S R Scott; R A Blouin
Journal:  Clin Pharmacol Ther       Date:  1988-04       Impact factor: 6.875

2.  The stereoselective interaction of warfarin and metronidazole in man.

Authors:  R A O'Reilly
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

3.  Application of moment analysis to nonlinear drug disposition described by the Michaelis-Menten equation.

Authors:  A T Chow; W J Jusko
Journal:  Pharm Res       Date:  1987-02       Impact factor: 4.200

4.  A Bayesian feedback method of aminoglycoside dosing.

Authors:  M E Burton; D C Brater; P S Chen; R B Day; P J Huber; M R Vasko
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

5.  Choosing optimal sampling times for therapeutic drug monitoring.

Authors:  G E Schumacher
Journal:  Clin Pharm       Date:  1985 Jan-Feb

6.  The effects of enzyme induction and enzyme inhibition on labetalol pharmacokinetics.

Authors:  T K Daneshmend; C J Roberts
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 7.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

8.  31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

Authors:  S Eleff; N G Kennaway; N R Buist; V M Darley-Usmar; R A Capaldi; W J Bank; B Chance
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

9.  Implications of intraindividual variability in bioavailability studies of furosemide.

Authors:  A Grahnén; M Hammarlund; T Lundqvist
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Interindividual and intraindividual variability in labetalol pharmacokinetics.

Authors:  W M Awni; D J Skaar; M H Schwenk; M A Sirgo; J R Plachetka; G R Matzke
Journal:  J Clin Pharmacol       Date:  1988-04       Impact factor: 3.126

View more
  4 in total

Review 1.  Formation of active metabolites of psychotropic drugs. An updated review of their significance.

Authors:  S Caccia; S Garattini
Journal:  Clin Pharmacokinet       Date:  1990-06       Impact factor: 6.447

Review 2.  Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.

Authors:  S Caccia
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

Review 3.  Pharmacokinetic studies in paediatric patients. Clinical and ethical considerations.

Authors:  R E Kauffman; G L Kearns
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

4.  Carbamazepine and its metabolites in neuralgias: concentration-effect relations.

Authors:  R S Moosa; M L McFadyen; R Miller; J Rubin
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.